Resources

This week we continue our special series on Diabetic Eye Disease with the second set of slides from Paul Chous….

Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mrs. MS was referred by a diabetes educator in a rural area to a metropolitan diabetes educator. Mrs. MS is 45 and has not had any medical assessment for 18 months. She is …

The US Food and Drug Administration (FDA) warned healthcare professionals to closely monitor patients with diabetes receiving liraglutide injections (Victoza, Novo Nordisk) for thyroid C-cell tumors and acute pancreatitis.…

by Daniel Schultz, PharmD Candidate UF College of Pharmacy   In spite of perceptions that they consider themselves young and invincible, a recent poll by the American Academy of Family Physicians reports that the majority of Americans aged 18 to 26 are taking an active role in maintaining their health …

A Monthly Test for Diabetes — The Epinex G1A™ Test  A monthly test for the control of glycation, the underlying cause of the complications of diabetes. The only rapid test for measuring glycated albumin, a marker for diabetes control. It allows for earlier therapeutic intervention, encourages self-management, promotes compliance and fulfills unmet …

A new study in VA patients has found no survival benefit associated with bariatric surgery among older, severely obese people when compared with usual care, at least out to seven years….

A low fat diet has led some doctors to worry that Americans would instead start eating too many carbohydrates but a new study suggests that eating low-fat doesn’t have to increase carbohydrate-fueled health risks….

Circulating 25-hydroxyvitamin D [25(OH)D] concentrations in postmenopausal women are directly associated with weight loss, whether achieved through lower caloric intake or increased physical activity….

  Balaglitazone, an experimental thiazolidinedione derivative, was slightly less effective than pioglitazone but had fewer side effects in patients with type 2 diabetes in a recent phase III trial.…

In a study, two months of treatment with the anti-inflammatory agent diacerein improved insulin secretion and dropped A1C levels in type 2 diabetes patients from 8.3% to 7.0%, within 60 days.…